CCM
DGX icon

Coldstream Capital Management’s Quest Diagnostics DGX Stock Holding History

Coldstream Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.73M Sell
13,948
-3,019
-18% -$587K 0.03% 224
2025
Q4 		$2.94M Sell
16,967
-66
-0.4% -$12K 0.04% 202
2025
Q3 		$3.25M Buy
17,033
+3
+0% +$532 0.04% 192
2025
Q2 		$3.06M Sell
17,030
-534
-3% -$92.8K 0.05% 196
2025
Q1 		$2.97M Sell
17,564
-1,224
-7% -$201K 0.06% 173
2024
Q4 		$2.83M Buy
18,788
+797
+4% +$124K 0.06% 183
2024
Q3 		$2.79M Buy
17,991
+744
+4% +$111K 0.06% 177
2024
Q2 		$2.36M Buy
17,247
+172
+1% +$23.6K 0.06% 169
2024
Q1 		$2.27M Buy
17,075
+3,112
+22% +$404K 0.06% 171
2023
Q4 		$1.93M Buy
13,963
+817
+6% +$107K 0.05% 183
2023
Q3 		$1.6M Sell
13,146
-110
-0.8% -$14.7K 0.05% 194
2023
Q2 		$1.86M Hold
13,256
– – 0.06% 183
2023
Q1 		$1.88M Buy
13,256
+195
+1% +$27.9K 0.06% 184
2022
Q4 		$2.04M Buy
+13,061
New +$1.88M 0.07% 162
2022
Q2 		$1.71M Buy
12,876
+526
+4% +$71.7K 0.07% 159
2022
Q1 		$1.69M Sell
12,350
-4,633
-27% -$646K 0.06% 166
2021
Q4 		$2.94M Buy
16,983
+8,569
+102% +$1.3M 0.09% 137
2021
Q3 		$963K Sell
8,414
-13,525
-62% -$1.98M 0.05% 184
2021
Q2 		$2.9M Buy
21,939
+12,519
+133% +$1.64M 0.12% 138
2021
Q1 		$1.21M Sell
9,420
-70
-0.7% -$8.63K 0.07% 159
2020
Q4 		$1.13M Buy
9,490
+1,394
+17% +$170K 0.07% 150
2020
Q3 		$927K Buy
8,096
+25
+0.3% +$2.95K 0.08% 145
2020
Q2 		$920K Sell
8,071
-1,723
-18% -$183K 0.08% 134
2020
Q1 		$786K Sell
9,794
-131
-1% -$13.6K 0.09% 124
2019
Q4 		$1.06M Sell
9,925
-330
-3% -$34.4K 0.09% 128
2019
Q3 		$1.1M Sell
10,255
-188
-2% -$19.3K 0.09% 128
2019
Q2 		$1.06M Sell
10,443
-90
-0.9% -$8.65K 0.09% 126
2019
Q1 		$947K Buy
10,533
+1,151
+12% +$99.7K 0.08% 145
2018
Q4 		$781K Buy
9,382
+539
+6% +$50.5K 0.08% 161
2018
Q3 		$954K Buy
8,843
+1,023
+13% +$112K 0.09% 149
2018
Q2 		$859K Buy
7,820
+335
+4% +$34.9K 0.09% 137
2018
Q1 		$751K Buy
7,485
+688
+10% +$70.5K 0.08% 151
2017
Q4 		$669K Buy
6,797
+29
+0.4% +$2.75K 0.07% 173
2017
Q3 		$634K Buy
6,768
+68
+1% +$7.22K 0.07% 176
2017
Q2 		$745K Buy
6,700
+505
+8% +$53.4K 0.1% 131
2017
Q1 		$608K Buy
6,195
+675
+12% +$64.3K 0.08% 137
2016
Q4 		$507K Buy
+5,520
New +$476K 0.08% 149
2016
Q3 		– Sell
-24,058
Closed -$1.96M – 230
2016
Q2 		$1.96M Buy
24,058
+162
+0.7% +$12.3K 0.35% 54
2016
Q1 		$1.71M Buy
+23,896
New +$1.6M 0.31% 63

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Coldstream Capital Management's DGX Position: Q1 2026 in Review

Coldstream Capital Management reduced its Quest Diagnostics (DGX) stake by 18% in Q1 2026, selling an estimated $587K and leaving 13,948 shares worth $2.73M. The position accounts for 0.03% of the portfolio, ranked #224.

Coldstream Capital Management first reported a position in DGX in Q1 2016 and has held it in 39 quarters since. The position peaked at $3.25M in Q3 2025. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Coldstream Capital Management held 13,948 shares of Quest Diagnostics worth $2.73M as of Q1 2026.
  • Coldstream Capital Management sold 3,019 Quest Diagnostics shares in Q1 2026, an estimated $587K.
  • Quest Diagnostics made up 0.03% of Coldstream Capital Management's portfolio in Q1 2026, its #224 holding.
  • Coldstream Capital Management first reported a position in Quest Diagnostics in Q1 2016 and has held it in 39 quarters since.
  • Coldstream Capital Management's Quest Diagnostics position peaked at $3.25M in Q3 2025.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.